|Articles|July 13, 2022
Data Integrity: an alternative approach to eliminate blind spots
Author(s)Telstar
This article presents a detailed mapping of processes and data flow to identify the gaps associated to Data Integrity for GxP processes managed by computerized system and/or manually.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Navigating AI, Sustainability, and Operational Resilience
2
Integrating AI and Machine Learning in Drug Discovery and Development
3
Pharmaceutical Supply Chain Resilience in a Shifting Market
4
Single-Use Systems Enable Commercial-Scale CGT Manufacturing
5